Key facts
- This page summarizes Robert E. Hoffman's Form 3 filing for FibroBiologics Inc. (FBLG).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Feb 2024, 19:45.
Robert E. Hoffman - 24 Jan 2024 Form 3 Insider Report for FibroBiologics Inc. (FBLG)
- Reporting relationship
- Director
- Issuer ticker
- FBLG
- Reported as of
- 24 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Feb 2024, 19:45:46 UTC
- Prior SEC filing
- 01 Sep 2023
- Next SEC filing
- 27 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Andersen, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert E. Hoffman filed Form 3 for FibroBiologics Inc. (FBLG) on 07 Feb 2024.
Change
- Previous filing in this sequence was filed on 01 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FBLG
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 24 Jan 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24 - Power of Attorney